Abstract
A patient with mantle cell lymphoma (MCL) of the pleomorphic blastoid subtype is reported. The disease was clinically aggressive and refractory to chemotherapy, and the patient survived only 2 months. Cytogenetically, a t(11;19;14)(q13;q13;q32) was found. Fluorescent in situ hybridization (FISH) and molecular analyses demonstrated involvement of the BCL1/CCND1 locus in a three-way translocation. In addition, subclonal abnormalities of the region 8q24 manifested either as a t(8;22)(q24;q11)/CMYC rearrangement or trisomy 8 were identified. The pathogenetic impact of this very uncommon association of BCL1/CCND1 and CMYC rearrangements in MCL is discussed and the literature is reviewed.
Similar content being viewed by others
References
Au WY, Horsman DE, Viswanatha DS, Connors JM, Klasa RJ, Gascoyne RD (2000) 8q24 Translocations in blastic transformation of mantle cell lymphoma. Haematologica 85:1225–1227
Avet-Loiseau H, Gerson F, Magrangeas F, Minvielle S, Harousseau JL, Bataille R (2001) Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood 98:3082–3086
Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L, Garcia JL, Flores T, Gonzalez M, Lopez-Guillermo A, Piris MA, Cardesa A, Montserrat E, Miro R, Campo E (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 93:4365–4374
Bentz M, Plesch A, Bullinger L, Stilgenbauer S, Ott G, Muller-Hermelink HK, Baudis M, Barth TF, Moller P, Lichter P, Dohner H (2000) t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 27:285–294
de Boer CJ, van Krieken JH, Schuuring E, Kluin PM (1997) Bcl-1/cyclin D1 in malignant lymphoma. Ann Oncol 8(Suppl 2):109–117
Davis M, Malcolm S, Rabbitts TH (1984) Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells. Nature 308:286–288
Fisher RI (1996) Mantle-cell lymphoma: classification and therapeutic implications. Ann Oncol 7(Suppl 6):S35–S39
Hao S, Sanger W, Onciu M, Lai R, Schlette EJ, Medeiros LJ (2002) Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol 15:1266–1272
Hernandez L, Hernandez S, Bea S, Pinyol M, Ferrer A, Bosch F, Nadal A, Fernandez PL, Palacin A, Montserrat E, Campo E (1999) c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin’s lymphomas. Leukemia 13:2087–2093
Hoffman B, Amanullah A, Shafarenko M, Liebermann DA (2002) The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21:3414–3421
ISCN (1995) In: Mitelman F (ed) An international system for human genetic nomenclature. Karger, Basel
Jaffe ES, Harris NL, Diebold J, Stein H, Vardiman JW (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. IARC, Lyon, pp 168–170
Lovec H, Grzeschiczek A, Kowalski MB, Moroy T (1994) Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 13:3487–3495
Martin-Subero JI, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent JA, Dyer MJ, Novo FJ, Calasanz MJ, Siebert R (2002) Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 98:470–474
Michaux L, Dierlamm J, Wlodarska I, Bours V, Van den Berghe H, Hagemeijer A (1997) t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. Cancer Genet Cytogenet 94:36–43
Mitelman F, Johansson B, Mertens F (eds) (2003) Database of chromosome aberrations in cancer. http://www.cgap.nic.nih.gov/Chromosomes/Mitelman
M’kacher R, Farace F, Bennaceur-Griscelli A, Violot D, Clausse B, Dossou J, Valent A, Parmentier C, Ribrag V, Bosq J, Carde P, Turhan AG, Bernheim A (2003) Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model. Cancer Genet Cytogenet 143:32–38
Nagy B, Lundan T, Larramendy ML, Aalto Y, Zhu Y, Niini T, Edgren H, Ferrer A, Vilpo J, Elonen E, Vettenranta K, Franssila K, Knuutila S (2003) Abnormal expression of apoptosis-related genes in haematological malignancies: over expression of MYC is poor prognostic sign in mantle cell lymphoma. Br J Haematol 120:434–441
Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S, Holte H, Delabie J, Staudt LM (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3:185–197
Tirier C, Zhang Y, Plendl H, Weber-Matthiesen K, Langer W, Heit W, Schlegelberger B (1996) Simultaneous presence of t(11;14) and a variant Burkitt’s translocation in the terminal phase of a mantle cell lymphoma. Leukemia 10:346–350
Vaishampayan UN, Mohamed AN, Dugan MC, Bloom RE, Palutke M (2001) Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy. Br J Haematol 115:66–68
Vizcarra E, Martinez-Climent JA, Benet I, Marugan I, Terol MJ, Prosper F, Marco J, Sanchez D, Ferrandez A, Tormo M, Sarsotti E, Ferrer R, Garcia M, Ortuno F, Montagud M, Garcia-Conde J (2001) Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features. Hematol J 2:234–241
de Vos S, Krug U, Hofmann WK, Pinkus GS, Swerdlow SH, Wachsman W, Grogan TM, Said JW, Koeffler HP (2003) Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV. Diagn Mol Pathol 12:35–43
Wlodarska I, Pittaluga S, Hagemeijer A, Wolf-Peeters C, Van den Berghe H (1999) Secondary chromosome changes in mantle cell lymphoma. Haematologica 84:594–599
Zhu Y, Hollmen J, Raty R, Aalto Y, Nagy B, Elonen E, Kere J, Mannila H, Franssila K, Knuutila S (2002) Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. Br J Haematol 119:905–915
Acknowledgments
The authors thank R. Siebert (Kiel, Germany) for providing IGL and BCL3 FISH probes. Probes for JH, Cκ, Cλ, and BCL6 were provided by R. Dalla-Favera (University Medical Center, New York, N.Y., USA). The pBcl-1B probe was provided by Y. Tsujimoto (Wistar Institute, Philadelphia, Pa., USA), probe pllq13-7 by T.H. Rabbitts (MRC, Cambridge, UK), probe pHS-11 by P. Gaudray (LGMCH, Nice, France), PRAD1 probe by A. Arnold (Endocrine Unit, Massachusetts General Hospital, Boston, Mass., USA). Probes pαl.4P and pα5B were gifts from T.W. McKeithan (University of Chicago, Chicago, Ill., USA), and the pP20 probe was provided by Dr D. Mathieu-Mahul (Hôpital Saint-Louis, Paris, France). We thank Betty Emanuel for excellent technical assistance and Rita Logist for clerical work. Part of the work was supported by a FWO grant no. G033801N. This text presents research results of the Belgian program of interuniversity poles of attraction initiated by the Belgian state, Prime Minister’s Office, Science Policy Programming. The scientific responsibility is assumed by the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Michaux, L., Wlodarska, I., Theate, I. et al. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome. Ann Hematol 83, 578–583 (2004). https://doi.org/10.1007/s00277-004-0879-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-004-0879-2